Noxious organism control composition having excellent physical properties

Abstract

An object of the present invention is to provide a noxious organism control composition that is excellent in suppressing crystal precipitation in a case of being stored at or below ordinary temperature and / or is excellent in the long-term emulsion stability in a case of dilution with water, even in a case where a plurality of noxious organism control components that differ in characteristic solubility in water are contained at a high concentration.　There is provided a noxious organism control composition, containing (1) at least one selected from the group consisting of poorly water-soluble noxious organism control components in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less, (2) at least one selected from the group consisting of easily water-soluble noxious organism control components in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less, (3) an aprotic polar solvent, and (4) an ether-type ionic surfactant.

Description

NOXIOUS ORGANISM CONTROL COMPOSITION HAVING EXCELLENT PHYSICAL PROPERTIES

[0001] The present invention relates to a noxious organism control composition that dissolves a poorly water-soluble noxious organism control component and an easily water-soluble noxious organism control component at a high concentration and has excellent stock solution stability and excellent emulsion stability. Priority is claimed on Japanese Patent Application No.2024-174542, filed October 3, 2024, the content of which is incorporated herein by reference.

[0002] Emulsions are generally known as one of compositions that have a noxious organism control effect. 　　　　In the related art, an emulsion contains a solvent that dissolves a noxious organism control component and a surfactant that emulsifies the solvent in a case of dilution with water, and the emulsion is used by being diluted with water. Therefore, a noxious organism control component is required to have high solubility in the emulsion for during storage at low temperatures and excellent emulsification stability in a case of dilution with water. The "noxious organism control component" includes so-called insecticides, fungicides, and herbicides.

[0003] Patent document 1 discloses an insecticidal composition containing an agricultural active chemical component, a solvent in which a dielectric constant (εr) is 5 or more and a transition energy (ET(30)) is 38 kcal / mol or more, a non-polar solvent, and a nonionic surfactant. In the document, N-methyl-2-pyrrolidone and N-butyl-2-pyrrolidone are exemplified as a solvent in which the dielectric constant (εr) is 5 or more and the transition energy (ET(30)) is 38 kcal / mol or more.

[0004] [PTL 1] Japanese Unexamined Patent Application, First Publication No. 2020-83756

[0005] However, in the related art disclosed in Patent Document 1, in a case of containing, at a high concentration, a plurality of noxious organism control components that differ in solubility in water in order to provide an agricultural chemical having a wide spectrum, it was not possible to ensure the suppression of crystal precipitation at or below ordinary temperature, and there was a problem in terms of the storage stability of the composition at or below ordinary temperature. In addition, means for ensuring long-term emulsification stability in a case of dilution with water by using an ether-type ionic surfactant has not been disclosed until now. 　　　　An object to be achieved by the present invention is to provide a noxious organism control composition that is excellent in suppressing crystal precipitation in a case of being stored at or below ordinary temperature and is excellent in the long-term emulsion stability in a case of dilution with water, even in a case where a plurality of noxious organism control components that differ in solubility in water are contained at a high concentration.

[0006] To solve the above-described problem, the inventors of the present invention carried out diligent studies and found that the problem can be solved by combining a solvent and a specific surfactant. In other words, it was found that a noxious organism control composition, which dissolves a poorly water-soluble noxious organism control component and an easily water-soluble noxious organism control component at a high concentration, is excellent in the suppressibility of crystal precipitation in a case of being stored at or below ordinary temperature and is excellent in the long-term emulsion stability in a case of dilution with water, is obtained, whereby the present invention has been completed.

[0007] That is, the present invention is as follows. 　　　　[1] A noxious organism control composition, containing: 　　　　(1) at least one kind of compound selected from the group consisting of poorly water-soluble noxious organism control components in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less; 　　　　(2) at least one kind of compound selected from the group consisting of easily water-soluble noxious organism control components in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less; 　　　　(3) an aprotic polar solvent; and 　　　　(4) an ether-type ionic surfactant. 　　　　[2] The noxious organism control composition according to [1], 　　　　wherein the compound described in (1) is at least one selected from the group consisting of a meta-diamide-based insecticide, an isoxazoline-based insecticide, a diamide-based insecticide, a phenylpyrazole-based insecticide, a neonicotinoid-based insecticide, and a pyrethroid-based insecticide, and 　　　　the compound described in (2) is at least one selected from the group consisting of a neonicotinoid-based insecticide, a pyridine-based insecticide, and an isoxazole-based fungicide. 　　　　[3] The noxious organism control composition according to [1] or [2], 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, piperflanilide, fluxametamide, isocycloseram, isoflualanam, chlorantraniliprole, cyantraniliprole, cyclaniliprole, tetratraniliprole, flubendiamide, nicofluprole, flupyrimin, and etofenprox. 　　　　[4] The noxious organism control composition according to [1] or [2], 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, nicofluprole, fluxametamide, and isocycloseram. 　　　　[5] The noxious organism control composition according to [1] or [2], 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, and fluxametamide. 　　　　[6] The noxious organism control composition according to [1] or [2], 　　　　wherein the compound described in (1) is broflanilide. 　　　　[7] The noxious organism control composition according to any one of [1] to [6], 　　　　wherein the compound described in (2) is at least one selected from the group consisting of dinotefuran, flonicamid, and hydroxyisoxazole. 　　　　[8] The noxious organism control composition according to any one of [1] to [6], 　　　　wherein the compound described in (2) is at least one selected from the group consisting of dinotefuran and flonicamid. 　　　　[9] The noxious organism control composition according to any one of [1] to [6], 　　　　wherein the compound described in (2) is dinotefuran.

[0010] The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent includes at least one or more selected from the group consisting of amides, ureas, and carbamates.

[0011] The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of cyclic amides, cyclic ureas, and cyclic carbamates.

[0012] The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of an N-alkyl pyrrolidone, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone (provided that an N-alkyl group has 1 to 8 carbon atoms).

[0013] The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent is any N-alkyl pyrrolidone selected from the group consisting of N-butyl-2-pyrrolidone or N-methyl-2-pyrrolidone, where the aprotic polar solvent may include at least one selected from the group consisting of the N-alkyl imidazolidinone which is 1,3-dimethyl-2-imidazolidinone, or the N-alkyl oxazolidinone which is 3-methyl-2-oxazolidinone.

[0014] .The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone or N-methyl-2-pyrrolidone.

[0015] The noxious organism control composition according to any one of [1] to [9], 　　　　wherein the aprotic polar solvent is N-butyl-2-pyrrolidone.

[0016] The noxious organism control composition according to any one of [1] to

[0015] , 　　　　wherein the ether-type ionic surfactant is an ether-type anionic surfactant.

[0017] The noxious organism control composition according to

[0016] , 　　　　wherein the ether-type anionic surfactant includes at least one selected from the group consisting of salts having a polyoxyalkylene aryl ether.

[0018] The noxious organism control composition according to

[0016] , 　　　　wherein the ether-type anionic surfactant includes at least one selected from a group consisting of polyoxyethylene distearyl phenyl ether sulfate and a polyoxyethylene tristearyl phenyl ether sulfate.

[0019] The noxious organism control composition according to any one of

[0001] to [6], 　　　　wherein the compound described in (1) is broflanilide, 　　　　and the compound described in (2) is dinotefuran.

[0020] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of amides, ureas, and carbamates.

[0021] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of cyclic amides, cyclic ureas, and cyclic carbamates.

[0022] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of an N-alkyl pyrrolidone, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone (provided that an N-alkyl group has 1 to 8 carbon atoms).

[0023] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, and 3-methyl-2-oxazolidinone.

[0024] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone or N-methyl-2-pyrrolidone.

[0025] The noxious organism control composition according to

[0019] , 　　　　wherein the aprotic polar solvent is N-butyl-2-pyrrolidone.

[0008] Hereinafter, polyoxyalkylene will be denoted as POA, and polyoxyethylene will be denoted as POE.

[0009] According to the present invention, it is possible to provide a noxious organism control composition that contains a poorly water-soluble noxious organism control component and an easily water-soluble noxious organism control component at a high concentration and is excellent in the suppressibility of crystal precipitation in a case of being stored at or below ordinary temperature and is excellent in the long-term emulsion stability in a case of dilution with water.

[0010] Hereinafter, embodiments of the present invention will be described. However, the present invention is not limited to the following embodiments and can be variously modified and implemented within the scope of the gist of the present invention.

[0011] In the present invention, "ordinary temperature" means "25°C" unless otherwise specified.

[0012] In the present invention, the poorly water-soluble noxious organism control component is defined as a noxious organism control component that is dissolved such that a solubility in water at 20°C is in a range of 0.00002 g / L or more and 0.200 g / L or less, preferably in a range of 0.0001 g / L or more and 0.030 g / L or less, more preferably in a range of 0.002 g / L or more and 0.020 g / L or less, and still more preferably in a range of 0.003 g / L or more and 0.015 g / L or less.

[0013] In the present invention, the easily water-soluble noxious organism control component is defined as a noxious organism control component that is dissolved such that a solubility in water at 20°C is in a range of 3.8 g / L or more and 500 g / L or less, preferably in a range of 5 g / L or more and 100 g / L or less, more preferably in a range of 10 g / L or more and 70 g / L or less, and still more preferably in a range of 20 g / L or more and 50 g / L or less.

[0014] For the solubility of each substance in water, the manufacturer's nominal value may be used, or an actually measured value may be used. In a case of actually measuring solubility in water, a measured value obtained according to the elution method or flask method defined by OECD 105 can be adopted.

[0015] The fact that the noxious organism control composition according to the present invention "contains, at a high concentration, a plurality of noxious organism control components that differ in solubility in water" means that it contains each of a poorly water-soluble noxious organism control component and an easily water-soluble noxious organism control component at a high concentration. More specifically, it means that a noxious organism control composition (stock solution) before being diluted with water contains 4% or more of the poorly water-soluble noxious organism control component as defined above, and contains 10% or more of the easily water-soluble noxious organism control component as defined above.Noxious organism control composition

[0016] The noxious organism control composition according to the present embodiment is a noxious organism control composition, containing: 　　　　(1) one selected from the group consisting of poorly water-soluble noxious organism control components in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less, 　　　　(2) at least one selected from the group consisting of easily water-soluble noxious organism control components in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less, 　　　　(3) an aprotic polar solvent, and 　　　　(4) an ether-type ionic surfactant. 　　　　The noxious organism control composition according to the present embodiment (hereinafter, simply referred to as "composition") is excellent in the suppressibility of the crystal precipitation of the noxious organism control component in the composition according to the present embodiment in a case of being stored at or below ordinary temperature. In addition, the composition according to the present embodiment has excellent emulsification stability in a case of the composition is diluted with water.

[0017] The poorly water-soluble noxious organism control component includes a poorly water-soluble insecticide, a poorly water-soluble fungicide, and a poorly water-soluble herbicide. The easily water-soluble noxious organism control component includes an easily water‐soluble insecticide, an easily water‐soluble fungicide, and an easily water‐soluble herbicide. The noxious organism control composition according to the present embodiment includes, as a poorly water-soluble noxious organism control component, any one or more of a poorly water-soluble insecticide, a poorly water-soluble fungicide, and a poorly water-soluble herbicide, and it includes, as an easily water-soluble noxious organism control component, any one or more of an easily water-soluble insecticide, an easily water-soluble fungicide, and an easily water-soluble herbicide. 　　　　Hereinafter, descriptions will be made for the respective components contained in the noxious organism control composition according to the present embodiment.(1) Poorly water-soluble noxious organism control component

[0018] The poorly water-soluble noxious organism control component may be any component, regardless of the kind thereof, as long as it is a component that is effective in controlling noxious organisms. The poorly water-soluble noxious organism control component is not particularly limited. However, examples thereof include a poorly water-soluble insecticide, a poorly water-soluble fungicide, and a poorly water-soluble herbicide, where a plurality of kinds thereof may also be blended. In a case of blending a plurality of kinds of poorly water-soluble noxious organism control components, a plurality of components may be combined in each of the poorly water-soluble insecticide, the poorly water-soluble fungicide, and the poorly water-soluble herbicide, and two or more kinds thereof may be combined regardless of the kind. The poorly water-soluble noxious organism control component is not particularly limited; however, 1 to 3 kinds thereof are preferably contained, 1 or 2 kinds thereof are more preferably contained, and one kind thereof is still more preferably contained. In addition, the physical form of the poorly water-soluble noxious organism control component is not particularly limited; however, examples thereof include a powder, a solid, or a liquid. In the present embodiment, it is preferable to contain at least one selected from a group consisting of a poorly water-soluble insecticide, a poorly water-soluble fungicide, and a poorly water-soluble herbicide, it is more preferable to contain at least one selected from a group consisting of a poorly water-soluble insecticide and a poorly water-soluble fungicide, and it is still more preferable to contain a poorly water-soluble insecticide.(2) Easily water-soluble noxious organism control component

[0019] The easily water-soluble noxious organism control component may be any component, regardless of the kind thereof, as long as it is a component that is effective in controlling noxious organisms. The easily water-soluble noxious organism control component is not particularly limited. However, examples thereof include an easily water-soluble insecticide, an easily water-soluble fungicide, and an easily water-soluble herbicide, where a plurality of kinds thereof may also be blended. In a case of blending a plurality of kinds of easily water-soluble noxious organism control components, a plurality of components may be combined in each of the easily water-soluble insecticide, the easily water-soluble fungicide, and the poorly water-soluble herbicide, and two or more kinds thereof may be combined regardless of the kind. The easily water-soluble noxious organism control component is not particularly limited; however, 1 to 3 kinds thereof is preferably contained, 1 or 2 kinds thereof is more preferably contained, and one kind thereof is still more preferably contained. In addition, the physical form of the easily water-soluble noxious organism control component is not particularly limited; however, examples thereof include a powder, a solid, or a liquid. In the present embodiment, it is preferable to contain at least one or more selected from a group consisting of a easily water-soluble insecticide, an easily water-soluble fungicide, and an easily water-soluble herbicide, it is more preferable to contain at least one selected from a group consisting of a easily water-soluble insecticide and an easily water-soluble fungicide, and it is still more preferable to contain an easily water-soluble insecticide.

[0020] The insecticide that is a noxious organism control component is not particularly limited. However, examples thereof include those exhibiting action as an acetylcholinesterase inhibitor, such as phosphocarb, alanycarb, butocarboxim, butoxycarboxim, thiodicarb, thiofanox, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, trimethacarb, XMC, allyxycarb, aldoxycarb, bufencarb, butacarb, carbanolate, metolcarb, xylylcarb, fenothiocarb, bendiocarb, triazamate, aminocarb, metham-sodium, acephate, azamethiphos, azinphos methyl, azinphos ethyl, ethephon, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlofenthion, dichlorvos, dicrotophos, dimethoate, dimethylvinphos, disulfoton, O-ethyl O-4-nitrophenyl phenyl phosphonothioate, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, isofenphos methyl, isocarbophos, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton methyl, parathion, parathion methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, thiometon, triazophos, trichlorfon, vamidothion, chlorthion, bromfenvinphos, bromophos, bromophos ethyl, butathiophos, carbophenothion, chlorphoxim, sulprofos, diamidafos, tetrachlorvinphos, propaphos, mesulfenfos, dioxabenzofos, etrimfos, oxydeprophos, formothion, fensulfothion, isazophos, imicyafos, isamidofos, thionazin, fosthietan, tribufos, amidithion, amidothioate, amiton, athidathion, butonate, and flupyrazofos; those exhibiting action as a GABAergic chloride ion channel blocker, such as chlordane, endosulfan, lindane, dienochlor, aldrin, camphechlor, chlordecone, and phenylpyrazole-based compounds (for example, ethiprole, fipronil, acetoprole, pyrafluprole, pyriprole, nicofluprole, and the like)); pyrethroid-based compounds exhibiting action as a sodium channel modulator (for example, acrinathrin, allethrin ((1R)-isomer), bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, ceta-cypermethrin, zeta-cypermethrin, cyphenothrin ((1R)-trans-isomer), deltamethrin, empenthrin ((EZ)-(1R)-isomer), esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, methothrin, metofluthrin, epsilon-metofluthrin, momfluorothrin, epsilon-momfluorothrin, permethrin, phenothrin ((1R)-trans-isomer), prallethrin, resmethrin, kadethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin ((1R)-isomer), tralomethrin, transfluthrin, ZXI8901, biopermethrin, furamethrin, profluthrin, flubrocythrinate, dimefluthrin, phenothrin, fluvalinate, insect flower (pyrethrin), DDT, methoxychlor, and the like); neonicotinoid-based compounds exhibiting action on a nicotinic acetylcholine receptor (for example, acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, nicotine, nicotine sulfate, anabasine, sulfoxaflor, flupyradifurone, triflumezopyrim, dichloromezothiaz, cycloxaprid, flupyrimin, and the like); those exhibiting action as an allosteric modulator of a nicotinic acetylcholine receptor, such as spinosad and spinetoram; those exhibiting action as a glutamatergic chloride channel allosteric modulator, such as abamectin, emamectin benzoate, lepimectin, and milbemectin; those exhibiting action as a juvenile hormone mimetic, such as hydroprene, kinoprene, methoprene, fenoxycarb, and pyriproxyfen; those exhibiting action as a non-specific inhibitor, such as methyl bromide, methyl iodide, ethylene dibromide, bis(2-chloroethyl) ether, 1-bromo-2-chloroethane, bromocyclen, carbon tetrachloride, bis(2,3,3,3-tetrachloropropyl) ether, 3-bromo-1-chloroprop-1-ene, chloropicrin, cryolite, sulfuryl fluoride, borax, boric acid, disodium octaborate, sodium metaborate, tartar emetic, morantel tartrate, dazomet, metam, and sodium carbamate; those exhibiting action on chordotonal organ TRPV channel, such as pymetrozine, pyrifluquinazon, tyclopyrazoflor, and afidopyropen; those exhibiting action on chitin synthase, such as etoxazole, clofentezine, diflovidazin, and hexythiazox; those exhibiting action as a mitochondrial ATP synthase inhibitor, such as diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, "c-12.5" propargite, and "c-12.6" tetradifon; those exhibiting action as an oxidative phosphorylation uncoupling agent that disrupt the proton gradient, such as binapacryl, dinobuton, chlorfenapyr, DNOC, sulfluramid, tralopyril, and dinocap; those exhibiting action on a nicotinic acetylcholine receptor, such as bensultap, cartap hydrochloride, and thiocyclam; those exhibiting action as a chitin biosynthesis inhibitor, such as monosultap, bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, fluazuron, and buprofezin; those exhibiting action as a molting inhibitor, such as cyromazine; those exhibiting action on a molting hormone receptor, such as chromafenozide, halofenozide, methoxyfenozide, and tebufenozide; those exhibiting action on an octopamine receptor, such as amitraz; those exhibiting action on mitochondrial electron transport complex III, such as hydramethylnon, acequinocyl, fluacrypyrim, and bifenazate; those exhibiting action on mitochondrial electron transport complex I, such as fenazaquin, fenpyroximate, pyridaben, pyrimidifen, tebufenpyrad, tolfenpyrad, and rotenone; those exhibiting action on a voltage-dependent sodium channel, such as indoxacarb and metaflumizone; those exhibiting action as an acetyl-CoA carboxylase inhibitor, such as spirodiclofen, spiromesifen, spirotetramat, and spiropidion; those exhibiting action as a mitochondrial electron transport chain complex IV inhibitor, such as aluminum phosphide, calcium phosphide, hydrogen phosphide, zinc phosphide, calcium cyanide, sodium cyanide, potassium cyanide, and hydrogen cyanide; those exhibiting action as a mitochondrial electron transport complex II inhibitors, such as cyenopyrafen, cyflumetofen, and pyflubumide; damide-based compounds exhibiting ryanodine receptor modulator activity (for example, chlorantraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, tetratraniliprole, cyhalodiamide, tetrachlorantraniliprole, and the like); those exhibiting action on a chordotonal organ, such as flonicamid; metadiamide-based compounds exhibiting action on a GABAergic chloride ion channel (for example, broflanilide, cyproflanilide, piperflanilide, and the like); isoxazoline-based compounds exhibiting action on a GABAergic chloride ion channel (for example, fluxametamide, sarolaner, lotilaner, isocycloseram, afoxolaner, fluralaner, isoflualanam, and the like); those exhibiting action on a calcium-activated potassium channel, such as acynonapyr; those exhibiting action on a mitochondrial electron transport chain complex III inhibitor - Q1 site energy metabolism, such as flometoquin; or the following compounds exhibiting unknown action, such as azadirachtin, benzoximate, phenisobromolate, quinomethionate, dicofol, pyridalyl, bromopropylate, dicyclanil, karanjin, mercuric chloride, methyl isothiocyanate, pentachlorophenol, phosphine, piperonyl butoxide, a sulcofuron salt (sulcofuron-sodium), aramite, azotoate, barium polysulfide, benclothiaz, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol, butopyronoxyl, 2-(2-butoxyethoxy)ethyl thiocyanate, chlorbenside, chlordimeform, chlorphenetole, chlorfenson, metaldehyde, levamisole hydrochloride, amidoflumet, diofenolan, chlorobenzilate, flufenzine, benzomate, flufenerim, albendazole, oxibendazole, fenbendazole, 1,3-dichloropropene, acrylonitrile, carbon disulfide, cymiazole, calcium polysulfide, cytokinin, 2-(octylthio)ethanol, potassium oleate, sodium oleate, soybean lecithin, starch, hydroxypropyl starch, fatty acid glyceride, propylene glycol mono fatty acid ester, diatomaceous earth, fluazaindolizine, tioxazafen, fluhexafon, fluensulfone, TPIC, D-D, peroxocarbonate, MB-599, DCIP, ENT-8184, Bayer 22408, Bayer 32394, BAI-1602, BAI-1603, S-1587, chloroprallethrin, benzpyrimoxan, polynactin complex, sabadilla, and nemadectin.

[0021] The water solubility of these insecticides is measured according to the above-described measurement method, whereby it is possible to determine whether the insecticide corresponds to a poorly water-soluble insecticide or an easily water-soluble insecticide. From the viewpoint of solubility in water, among the insecticides described above, a substance that does not correspond to any of the poorly water-soluble insecticide and the easily water-soluble insecticide can be used in combination in a range where the effect of the present invention is not impaired.

[0022] The poorly water-soluble insecticide is not particularly limited. However, from the viewpoint of more effectively exhibiting the action effect, among the insecticides having a solubility of 0.00002 g / L or more and 0.200 g / L or less at 20°C in water, it is, for example, preferably chlordane, endosulfan, lindane, dienochlor, aldrin, chlordecone, phenylpyrazole-based (for example, ethiprole, fipronil, pyrafluprole, nicofluprole, and the like), pyrethroid-based compounds (for example, bifenthrin, cycloprothrin, esfenvalerate, etofenprox, flucythrinate, metofluthrin, resmethrin, tetramethrin, tralomethrin, flubrocythrinate, phenothrin, insect flower (pyrethrin, and the like), DDT, and methoxychlor, diamide-based compounds (for example, chlorantraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, tetratraniliprole, cyhalodiamide, tetrachlorantraniliprole, and the like), metadiamide-based compounds (for example, broflanilide, cyproflanilide, piperflanilide, and the like), isoxazoline-based compounds (for example, fluxametamide, sarolaner, lotilaner, isocycloseram, afoxolaner, fluralaner, and isoflualanam), pymetrozine, pyrifluquinazon, afidopyropen, thiacloprid, dichloromezothiaz, cycloxaprid, or neonicotinoid-based compounds (for example, flupyrimin); more preferably etofenprox, flupyrimin, nicofluprole, chlorantraniliprole, cyantraniliprole, tetratraniliprole, flubendiamide, cyclaniliprole, cyproflanilide, piperflanilide, broflanilide, fluxametamide, isoflualanam, and isocycloseram; still more preferably nicofluprole, cyproflanilide, broflanilide, fluxametamide, and isocycloseram; particularly preferably broflanilide, fluxametamide, and cyproflanilide; and more particularly preferably broflanilide.

[0023] The easily water-soluble insecticide is not particularly limited. However, from the viewpoint of more effectively exhibiting the action effect, among the insecticides having a solubility of 3.8 g / L or more and 500 g / L or less at 20°C in water, it is, for example, more preferably a pyridine-based insecticide (for example, flonicamid) or a neonicotinoid-based insecticide (for example, acetamiprid, dinotefuran, imidacloprid, thiamethoxam, nicotine sulfate, or the like), which exhibits action on a chordate organ; still more preferably dinotefuran or flonicamid; and even still more preferably dinotefuran.

[0024] The fungicide that is a noxious organism control component is not particularly limited. However, examples thereof include those exhibiting action on the nucleic acid synthesis metabolism, such as benalaxyl, benalaxyl M, or chiralaxyl, oxadixyl, furalaxyl, metalaxyl, metalaxyl M, or mefenoxam, ofurace, bupirimate, dimethirimol, ethirimol, isoxazole-based compound(for example, hydroxyisoxazole (hymexazol)), octhilinone, and oxolinic acid; those exhibiting action on a cytoskeleton and a motor protein, such as benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate, thiophanate methyl, diethofencarb, zoxamide, ethaboxam, pencycuron, fluopicolide, phenamacril, metrafenone, and pyriofenone; those exhibiting action on respiration, such as diflumetorim, benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penthiopyrad, penflufen, pydiflumetofen, sedaxane, thifluzamide, pyraziflumide, inpyrfluxam, fluindapyr, isoflucypram, azoxystrobin, coumoxystrobin, dimoxystrobin, enoxastrobin, famoxadone, fenamidone, fenaminstrobin, flufenoxystrobin, fluoxastrobin, kresoxim methyl, mandestrobin, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, triclopyricarb, trifloxystrobin, cyazofamid, amisulbrom, fenpicoxamid, binapacryl, meptyldinocap, dinocap, fluazinam, ferimzone, triphenyltin acetate, triphenyltin chloride, triphenyltin hydroxide, silthiofam, ametoctradin, and an amino acid; those exhibiting action on the protein biosynthesis, such as cyprodinil, mepanipyrim, pyrimethanil, blasticidin S, kasugamycin, streptomycin, and oxytetracycline; those exhibiting action on the signal transduction, such as quinoxyfen, proquinazid, fenpiclonil, fludioxonil, chlozolinate, dimethachlon, iprodione, procymidone, and vinclozolin; those exhibiting action on the lipid biosynthesis or the structure or function of the transport cell membrane, such as edifenphos, iprobenfos, pyrazophos, isoprothiolane, biphenyl, chloroneb, dichloran, quintozene, tecnazene, tolclofos methyl, etridiazole, iodocarb, propamocarb, prothiocarb, and oxathiapiprolin; azole-based compounds exhibiting action on the sterol biosynthesis in cell membranes (for example, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole M, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fluquinconazole, quinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, nuarimol, oxpoconazole, oxpoconazole fumarate, pefurazoate, penconazole, prochloraz, propiconazole, prothioconazole, pyrifenox, pyrisoxazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triforine, triticonazole, mefentrifluconazole, ipfentrifluconazole, F-69 (2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol), aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine, fenhexamid, fenpyrazamine, pyributicarb, naftifine, terbinafine, and the like); polyoxin-based compounds those exhibiting action on the cell wall biosynthesis, such as dimethomorph, flumorph, pyrimorph, benthiavalicarb, benthiavalicarb isopropyl, iprovalicarb, mandipropamid, and valifenalate; those exhibiting action on the melanin synthesis in cell walls, such as fthalide, pyroquilon, tricyclazole, fenoxanil, carpropamid, diclocymet, and tolprocarb; those exhibiting action on the induction of resistance in host plants, such as acibenzolar-S-methyl, probenazole, tiadinil, isotianil, laminarin, fosetyl, phosphorous acid, a sodium salt of phosphorous acid, an ammonium salt of phosphorous acid, a potassium salt of phosphorous acid, and dichlobentiazox; an extract (BLAD) from cotyledons of lupin seedlings, which acts as a biological agricultural chemical; those exhibiting multifunctional point contact activity, such as mancozeb, manzeb, copper oxychloride, copper (II) hydroxide, a basic copper sulfate, an organocopper compound, and dodecylbenzenesulfonic acid bis(ethylenediamine) copper complex salt (II); halogen-based compounds (for example, iodopropynyl butylcarbamate (IPBC), sanplus, diiodomethyl-p-tolysulfone(DMTS)), maneb, metiram, propineb, thiuram, zineb, ziram, ferbam, captan, captafol, folpet, fluorofolpet, guazatine, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, sulfur, fluoroimide, chlorothalonil, dichlofluanid, tolylfluanid, anilazine, dithianon, and quinomethionate; carbamate-based compound (for example, methasulfocarb and the like); or the following compounds exhibiting unknown action, such as validamycins, dipymetitrone, tecloftalam, triazoxide, flusulfamide, diclomezine, cyflufenamid, dodine, flutianil, tebufloquin, picarbutrazox, cymoxanil, quinofumelin, NC-241, NF-180, S-2190, S-2367, and aminopyrifen.

[0025] The solubility of these fungicides in water is measured according to the above-described measurement method, whereby it is possible to determine whether the fungicides corresponds to a poorly water-soluble fungicide or an easily water-soluble fungicide. From the viewpoint of solubility in water, among the fungicides described above, a substance that does not correspond to any of the poorly water-soluble fungicide and the easily water-soluble fungicide can be used in combination in a range where the effect of the present invention is not impaired.

[0026] The poorly water-soluble fungicide is not particularly limited. However, from the viewpoint of more effectively exhibiting the action effect, among the insecticides having a solubility of 0.00002 g / L or more and 0.200 g / L or less at 20°C in water, it is, for example, preferably fenpropimorph, tridemorph, fenpropidin, piperalin, fenhexamid, fenpyrazamine, pyributicarb, naftifine, mancozeb, manzeb, copper oxychloride, copper (II) hydroxide, diiodomethyl-p-tolylsulfone, maneb, propineb, thiuram, ziram, captan, captafol, folpet, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, fluoroimide, dichlofluanid, tolylfluanid, dithianon, quinomethionate, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenarimol, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, nuarimol, oxpoconazole, oxpoconazole fumarate, prochloraz, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triforine, triticonazole, mefentrifluconazole, ipfentrifluconazole, F-69 (2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol), oxadixyl, ethirimol, octhilinone , or oxolinic acid; more preferably F-69 (2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol) or simeconazole; and still more preferably simeconazole.

[0027] The easily water-soluble fungicide is not particularly limited. However, among the fungicides having a solubility of 3.8 g / L or more and 500 g / L or less at 20°C in water, it is, for example, preferably metalaxyl, metalaxyl M, or mefenoxam, or hydroxyisoxazole (hymexazol) which exhibits action on the nucleic acid synthesis metabolism, and it is more preferably hydroxyisoxazole (hymexazol) from the viewpoint of more effectively exhibiting the action effect.

[0028] The herbicide that is a noxious organism control component is not particularly limited. However, examples thereof include those exhibiting inhibitory action on acetyl CoA carboxylase, such as butroxydim, profoxydim, clethodim, tepraloxydim, tralkoxydim, sethoxydim, cycloxydim, propaquizafop, quizalofop, haloxyfop, fluazifop butyl, fluazifop-P-butyl, cyhalofop butyl, clodinafop-propargyl, diclofop methyl, fenoxaprop-P-ethyl, and pinoxaden; those exhibiting inhibitory action on acetolactate synthase, such as amidosulfuron, azimsulfuron, trifloxysulfuron, bensulfuron methyl, cyclosulfamuron, flupyrsulfuron methyl, foramsulfuron, chlorimuron ethyl, ethametsulfuron methyl, halosulfuron methyl, nicosulfuron, chlorsulfuron, ethoxysulfuron, imazosulfuron, oxasulfuron, pyrazosulfuron ethyl, tritosulfuron, cinosulfuron, flazasulfuron, iodosulfuron methyl, primisulfuron methyl, rimsulfuron, thifensulfuron methyl, mesosulfuron methyl, metsulfuron methyl, prosulfuron, triasulfuron, triflusulfuron methyl, sulfosulfuron, tribenuron methyl, trifloxysulfuron, flucarbazone, propoxycarbazone, bispyribac, pyribenzoxim, pyrithiobac, pyriftalid, pyriminobac methyl, cloransulam methyl, diclosulam, florasulam, flumetsulam, metosulam, penoxsulam, imazapic, imazapyr, imazamethabenz methyl, imazaquin, imazamox, and imazethapyr; those exhibiting inhibitory action on photosynthesis, such as desmedipham, phenmedipham, bromacil, lenacil, terbacil, methabenzthiazuron, hexazinone, metamitron, metribuzin, ametryn, atrazine, dimethametryn, cyanazine, prometryn, simazine, simetryn, amicarbazone, chloridazon, chlorotoluron, fluometuron, isoproturon, isouron, diuron, linuron, tebuthiuron, carbutyrate, propanil, ioxynil, bromoxynil, bentazon, and pyridate; those exhibiting the photosystem I electron conversion action, such as paraquat and diquat; those exhibiting inhibitory action on protoporphyrinogen oxidase, such as acifluorfen, bifenox, fomesafen, lactofen, oxyfluorfen, carfentrazone ethyl, sulfentrazone, oxadiargyl, oxadiazone, butafenacil, saflufenacil, pyraflufen ethyl, cinidon ethyl, flumiclorac-pentyl, flumioxazin, thiafenacil, and trifludimoxazine; those exhibiting whitening action, such as picolinafen, fluridone, norflurazon, diflufenican, beflubutamid, flurochloridone, flurtamone, pyrazolate, pyrazoxyfen, benzofenap, topramezone, pyrasulfotole, tolpyralate, mesotrione, sulcotrione, benzobicyclon, tefuryltrione, tembotrione, bicyclopyrone, fenquinotrione, lancotrione, isoxaflutole, and clomazone; those exhibiting inhibitory action on 5-enolpyruvylshikimate-3-phosphate synthase, such as glyphosate; those exhibiting inhibitory action on glutamine synthase, such as glufosinate and bialaphos; those exhibiting inhibitory action on dihydropteroate synthase, such as asulam; those exhibiting inhibitory action on microtubule polymerization, such as benfluralin, ethalfluralin, pendimethalin, butralin, oryzalin, trifluralin, dithiopyr, thiazopyr, acetochlor, butachlor, alachlor, dimethachlor, dimethenamid, propachlor, thenylchlor, metazachlor, metolachlor, S-metolachlor, pretilachlor, pethoxamid, benthiocarb, butyrate, esprocarb, molinate, dimepiperate, orbencarb, prosulfocarb, triallate, pyroxasulfone, fenoxasulfone, and ipfencarbazone; those exhibiting inhibitory action on cellulose synthesis, such as dichlobenil and indaziflam; those exhibiting indole acetic acid-like activity, such as triclopyr, clopyralid, fluroxypyr, picloram, quinclorac, quinmerac, clomeprop, MCPA, MCPB, 2,4-DB, dicamba, benazolin, aminocyclopyrachlor, halauxifen methyl, and florpyrauxifen benzyl; those exhibiting inhibitory action on auxin transport, such as diflufenzopyr and naptalam; those exhibiting inhibitory action on solanesyl diphosphate synthase, such as aclonifen; those exhibiting inhibitory action on homogentisate solanesyltransferase, such as cyclopyrimorate; or, napropamide or tetrapion.

[0029] The solubility of these herbicides in water is measured according to the above-described measurement method, whereby it is possible to determine whether the herbicide corresponds to a poorly water-soluble herbicide or an easily water-soluble herbicide. From the viewpoint of solubility in water, among the herbicides described above, a substance that does not correspond to any of the poorly water-soluble herbicide and the easily water-soluble herbicide can be used in combination in a range where the effect of the present invention is not impaired.

[0030] The poorly water-soluble herbicide is not particularly limited. However, from the viewpoint of more effectively exhibiting the action effect, among the herbicides having a solubility of 0.00002 g / L or more and 0.200 g / L or less at 20°C in water, it is, for example, preferably benzobicyclon, tolpyralate, pyrazoxyfen, pyrazolate, pyrasulfotole, benzofenap, isoxaflutole, cyclopyrimorate, and napropamide, more preferably benzobicyclon, cyclopyrimorate, and pyrazolate, and still more preferably pyrazolate.

[0031] The easily water-soluble herbicide is not particularly limited. However, from the viewpoint of more effectively exhibiting the action effect, among the herbicides having a solubility of 3.8 g / L or more and 500 g / L or less at 20°C in water, it is, for example, preferably glyphosate, glufosinate, tefuryltrione, mesotrione, fenquinotrione, and bicyclopyrone, more preferably glyphosate, glufosinate, and tefuryltrione, and still more preferably glufosinate and glyphosate.

[0032] The noxious organism control composition of the present embodiment is constituted by appropriately combining (1) the poorly water-soluble noxious organism control component and (2) the easily water-soluble noxious organism control component, which are described above. It is preferable that (1) the poorly water-soluble noxious organism control component that is contained in the noxious organism control composition is at least one selected from the group consisting of a meta-diamide-based insecticide, an isoxazoline-based insecticide, a diamide-based insecticide, a phenylpyrazole-based insecticide, a neonicotinoid-based insecticide, and a pyrethroid-based insecticide (2) the easily water-soluble noxious organism control component that is contained in the noxious organism control composition is at least one selected from the group consisting of a neonicotinoid-based insecticide, a pyridine-based insecticide, and an isoxazole-based insecticide.

[0033] Further, (2) the easily water-soluble noxious organism control component that is contained in the noxious organism control composition is preferably at least one selected from the group consisting of dinotefuran, flonicamid, and hydroxyisoxazole, more preferably at least one selected from the group consisting of dinotefuran and flonicamid, and still more preferably dinotefuran.

[0034] The content of (1) poorly water-soluble noxious organism control component may be any content as long as the formulation is possible. Although not particularly limited, for example, from the viewpoint of the manufacturability or the physical properties of the composition, it is generally 0.1% to 30% by mass, preferably 1% to 25% by mass, more preferably 2% to 20% by mass, still more preferably 3% to 15% by mass, and still more preferably 4% to 10% by mass, with respect to 100% by mass of the composition according to the present embodiment. In a case where the content of the poorly water-soluble noxious organism control component is 30% by mass or less, the crystal suppressibility tends to be further improved, and in a case where it is 0.1% by mass or more, the noxious organism control effect tends to be further improved. 　　　　The content of the noxious organism control component in the composition may be determined based on the charge ratio at the time of manufacturing the composition, or it may be determined using an analytical instrument such as HPLC, according to an external standard method or an internal standard method.

[0035] The content of (2) easily water-soluble noxious organism control component may be any content as long as the formulation is possible. Although not particularly limited, for example, from the viewpoint of the manufacturability or the physical properties of the composition, it is generally 0.1% to 40% by mass, preferably 1% to 35% by mass, more preferably 5% to 30% by mass, still more preferably 10% to 25% by mass, and still more preferably 12% to 20% by mass, with respect to 100% by mass of the composition according to the present embodiment. In a case where the content of the easily water-soluble noxious organism control component is 30% by mass or less, the crystal suppressibility tends to be further improved, and in a case where it is 0.1% by mass or more, the noxious organism control effect tends to be further improved. 　　　　The content of the noxious organism control component in the composition may be determined based on the charge ratio at the time of manufacturing the composition, or it may be determined using an analytical instrument such as HPLC, according to an external standard method or an internal standard method.(3) Aprotic polar solvent

[0036] Although not particularly limited, the aprotic polar solvent is preferably at least one selected from the group consisting of solvents of amides, ureas, and carbamates. As the aprotic polar solvent, publicly known solvents of amides, ureas, or carbamates can be used. The aprotic polar solvent is more preferably at least one selected from the group consisting of cyclic amides, cyclic ureas, and cyclic carbamates. The cyclic structure of each solvent is preferably a 4 to 7-membered ring structure, more preferably a 5 to 6-membered ring structure, and particularly preferably a solvent containing a 5-membered ring structure. Although not particularly limited, the aprotic polar solvent is, for example, preferably at least one selected from the group consisting of an N-alkyl lactam, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone from the viewpoint of more effectively exhibiting the action effect. Each of the alkyl groups bonded to the nitrogen atom preferably has 1 to 8 carbon atoms and more preferably has 1 to 4 carbon atoms.

[0037] The aprotic polar solvent is preferably at least one selected from the group consisting of an N-alkyl pyrrolidone, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone, and more preferably at least one selected from the group consisting of N-butyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, and 3-methyl-2-oxazolidinone.

[0038] Among the above, the aprotic polar solvent is more preferably an N-alkyl lactam. Although not particularly limited, the N-alkyl lactam is preferably an N-alkyl pyrrolidone, more preferably N-methyl-2-pyrrolidone or N-butyl-2-pyrrolidone, and still more preferably N-butyl-2-pyrrolidone.

[0039] One kind or two kinds of aprotic polar solvents can be contained in combination; however, in a case of using two or more kinds of amide-based solvents, it is preferable to include N-butyl-2-pyrrolidone. The content of the aprotic polar solvent may be any content as long as the formulation is possible. Although not particularly limited, from the viewpoint of more effectively exhibiting the action effect, it is preferably 40% to 95% by mass, more preferably 50 to 90% by mass, and still more preferably 60% to 85% by mass, with respect to 100% by mass of the composition according to the present embodiment. The content of the aprotic polar solvent in the composition may be determined based on the charge ratio at the time of manufacturing the composition, or it may be determined using an analytical instrument such as GC, according to an external standard method or an internal standard method.(4) Ether-type ionic surfactant

[0040] Among the ether-type anionic surfactant, the ether-type cationic surfactant, and the ether-type amphoteric surfactant, the ether-type ionic surfactant is preferably an ether-type anionic surfactant or an ether-type cationic surfactant, and from the viewpoint of more effectively exhibiting the action effect, it is more preferably an ether-type anionic surfactant. 　　　　The ether-type anionic surfactant is an anionic surfactant that has an aryl ether structure within the molecule thereof. Examples of the ether-type anionic surfactant having an aryl ether include a compound having an aryl ether structure and a polyoxyalkylene structure in the molecule, examples of which include a compound in which an aryl group is bonded to a polyoxyalkylene group through an ether bond. Examples of the aryl group include a phenyl group, a naphthyl group, and a benzyl group, and the aryl group may be modified with a substituent. 　　　　In the present specification, the polyoxyalkylene, the polyoxyalkylene structure, and the polyoxyalkylene group are used to describe similar structures, respectively. However, although not particularly limited, polyoxyalkylene is polyoxyethylene, polyoxypropylene, polyoxyisopropylene, or polyoxytrimethylene, preferably polyoxyethylene or polyoxyisopropylene, and more preferably polyoxyethylene. 　　　　In the ether-type anionic surfactant, although not particularly limited, the aryl group in the aryl ether structure may be modified with, for example, an allyl group, modified with a styryl group, or may be styrenated. Although not particularly limited, examples of the aryl group in the aryl ether structure include a polystyrylphenyl group, a tris(styryl)phenyl group, a dis(styryl)phenyl group, and a monos(styryl)phenyl groups (styrylphenyl group). 　　　　The ether-type anionic surfactant may be a compound (polyoxyalkylene aryl ether) in which the aryl group and the polyoxyalkylene group are bonded through an ether bond, or it may be a compound of any combination of the aryl group and the polyoxyalkylene group. That is, it may be an anionic surfactant having a phenyl ether, an anionic surfactant having a naphthyl ether, or an anionic surfactant having a benzyl ether. Among them, it is preferably a compound (an anionic surfactant having a phenyl ether) in which the phenyl group and the polyoxyalkylene group are bonded through an ether bond. 　　　　Although not particularly limited, examples of the anionic surfactant having a phenyl ether include a polyoxyalkylene polystyryl phenyl ether, a polyoxyalkylene tristyryl phenyl ether, a polyoxyalkylene distyryl phenyl ether, a polyoxyalkylene styryl phenyl ether, a polyoxyalkylene allyl phenyl ether, a polyoxyalkylene distyrenated phenyl ether, and a polyoxyalkylene styrenated phenyl ether, where polyoxyethylene polystyryl phenyl ether, polyoxyethylene tristyryl phenyl ether, polyoxyethylene distyryl phenyl ether, polyoxyethylene styryl phenyl ether, polyoxyethylene allyl phenyl ether, polyoxypropylene allyl phenyl ether, polyoxyisopropylene allyl phenyl ether, polyoxyethylene distyrenated phenyl ether, and polyoxyethylene styrenated phenyl ether are preferable. 　　　　Although not particularly limited, examples of the anionic surfactant having a naphthyl ether include a polyoxyalkylene naphthyl ether and a polyoxyalkylene allyl naphthyl ether, where polyoxyethylene naphthyl ether is more preferable, and polyoxyethylene β-naphthyl ether is preferable. 　　　　Although not particularly limited, examples of the anionic surfactant having a benzyl ether include a polyoxyalkylene benzyl ether and a polyoxyalkylene allyl benzyl ether, where polyoxyethylene benzyl ether is preferable. 　　　　In the present embodiment, the ether-type ionic surfactant may be used alone, or it can be used in combination with other surfactants. In addition, among ether-type ionic surfactants, the ether-type anionic surfactant is obtained by sulfating a terminal hydroxyl group of a polyoxyethylene alkyl ether, and it is preferable to contain an ammonium ion or a sodium ion as a counter ion. 　　　　The ether-type anionic surfactant preferably includes at least one selected from salts having a polyoxyalkylene aryl ether. In addition, the ether-type anionic surfactant preferably includes at least one selected from a polyoxyethylene distearyl phenyl ether sulfate and a polyoxyethylene tristearyl phenyl ether sulfate. 　　　　The ether-type cationic surfactant is obtained by subjecting a terminal amino group of a polyoxyethylene alkyl ether to quaternary amination, and it is preferable to contain a halogen anion or a sulfate anion as a counter ion. 　　　　In addition, one kind or two kinds of ether-type ionic surfactants can be contained in combination.

[0041] Although not particularly limited, the number of moles of alkylene oxide added in the ether-type ionic surfactant is preferably 3 to 30, more preferably 5 to 25, and still more preferably 9 to 20 from the viewpoint of more effectively exhibiting the action effect. 　　　　In addition, one kind or two kinds of ether-type anionic surfactants can be contained in combination. 　　　　Although not particularly limited, the number of moles of alkylene oxide added in the ether-type anionic surfactant is preferably 3 to 30, more preferably 5 to 25, and still more preferably 9 to 20 from the viewpoint of more effectively exhibiting the action effect.

[0042] Although not particularly limited, the content of the ether-type ionic surfactant is generally 0.5% to 20% by mass and preferably 1% to 10% by mass with respect to 100% by mass of the composition according to the present embodiment. In a case where the content of the ether-type ionic surfactants is within the above-described range, it is possible to prevent the composition from being separated or crystallized in a case where the composition is stored at or below ordinary temperature, and to prevent the uniformity from being impaired due to the occurrence of crystal precipitation in a case of being used by dilution with water. 　　　　The content of the ether-type ionic surfactant in the composition may be determined based on the charge ratio at the time of manufacturing the composition or may be determined using an analytical instrument such as HPLC, according to an external standard method or an internal standard method.(5) Other components

[0043] Any other components can be added to the composition according to the present embodiment. Examples of the other components include surfactants other than the ether-type ionic surfactant, coloring agents, solvents and oils, sugars, water-soluble polymers, inorganic salts, ultraviolet shielding agents, latexes and emulsions, anti-foaming agents, pH adjusting agents, and flavoring agents.

[0044] Although not particularly limited, examples of the surfactant other than the ether-type ionic surfactant include a nonionic surfactant, an anionic surfactant that is an ionic surfactant which does not include the ether-type ionic surfactant, a cationic surfactant, and an amphoteric surfactant.

[0045] Although not particularly limited, examples of the nonionic surfactant include an ether-type nonionic surfactant, an ester-type nonionic surfactant, an ester ether-type nonionic surfactant, and a nitrogen-containing-type nonionic surfactant.

[0046] Although not particularly limited, examples of the ether-type nonionic surfactant include a polyoxyethylene alkyl ether and a polyoxyethylene alkyl phenyl ether.

[0047] Although not particularly limited, examples of the ester-type nonionic surfactant include a glycerin fatty acid partial ester, a sorbitan fatty acid ester, a pentaerythritol fatty acid ester, a propylene glycol mono-fatty acid ester, and a sucrose fatty acid ester.

[0048] Although not particularly limited, examples of the ester ether-type nonionic surfactant include a polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene sorbitol fatty acid ester, a polyoxyethylene glycerin fatty acid ester, a polyethylene glycol fatty acid ester, a polyglycerin fatty acid partial ester, and a polyoxyethylene castor oil ether.

[0049] Although not particularly limited, examples of the nitrogen-containing-type nonionic surfactant include a fatty acid diethanolamide, an N,N-bis-2-hydroxyalkylamine, a polyoxyethylene alkylamine, a triethanolamine fatty acid ester, and a trialkylamine oxide.

[0050] Although not particularly limited, examples of the anionic surfactant include a carboxylate-type anionic surfactant, a sulfonate-type anionic surfactant, a sulfate ester salt-type anionic surfactant, a phosphate ester salt-type anionic surfactant, a polymeric macromolecule-type anionic surfactant, and a polycondensation-type anionic surfactant.

[0051] Although not particularly limited, examples of the carboxylate-type anionic surfactant include an aliphatic monocarboxylate, an N-acyl sarcosine salt, an N-acyl-β-alanine salt, an N-acyl glutamate, and an abietate.

[0052] Although not particularly limited, examples of the sulfonate-type anionic surfactant include a dialkyl sulfosuccinate, an alkane sulfonate, a hydroxy alkane sulfonate, a linear alkylbenzene sulfonate, an alkyl (branched) benzene sulfonate, an alkyl naphthalene sulfonate, an alkyl phenoxypolyoxyethylene propyl sulfonate, a polyoxyethylene alkyl phenol sulfonate, a naphthalene sulfonate-formaldehyde condensate, an N-methyl-N-oleyl taurine sodium, an N-alkyl sulfosuccinate mono-amide disodium salt, and a petroleum sulfonate.

[0053] Although not particularly limited, examples of the sulfate ester salt-type anionic surfactant include sulfated castor oil, sulfated beef foot oil, a sulfate ester salt of a fatty acid alkyl ester, an alkyl sulfate ester salt, a polyoxyethylene alkyl ether sulfate ester salt, a fatty acid monoglyceride sulfate ester salt, a polyoxyethylene alkyloyl amide sulfate, a polyoxyethylene alkyl phenyl ether sulfate ester salt, and a polyoxyethylene styryl phenyl ether sulfate ester salt.

[0054] Although not particularly limited, examples of the phosphate ester salt-type anionic surfactant include an alkyl phosphate ester salt, a polyoxyethylene alkyl ether phosphate ester salt, and a polyoxyethylene alkyl phenyl ether phosphate ester salt. Examples of the polymeric macromolecule-type and polycondensation-type anionic surfactants include a partially saponified product of a styrene-maleic anhydride copolymer, a partially saponified product of an olefin-maleic anhydride copolymer, and a naphthalene sulfonate-formaldehyde condensate.

[0055] Although not particularly limited, examples of the cationic surfactant include an alkyl amine, an alkyl quaternary ammonium salt, an ethylene oxide adduct of an alkyl amine, and an ethylene oxide adduct of an alkyl quaternary ammonium salt.

[0056] Although not particularly limited, examples of the alkyl amine include dodecyl dimethyl ammonium. Examples of the quaternary ammonium salt include a monoalkyl-type quaternary ammonium salt (such as cetyltrimethylammonium chloride or stearyltrimethylammonium chloride), a monoalkyl ether-type quaternary ammonium salt (such as stearoxypropyltrimethylammonium chloride or behenyl PG trimethylammonium chloride), a dialkyl-type quaternary ammonium salt (such as distearyl dimonium chloride or dicocodimonium chloride), and a benzalkonium-type quaternary ammonium salt.

[0057] Although not particularly limited, examples of the amphoteric surfactant include a betaine-type surfactant and an amino acid-type surfactant.

[0058] Although not particularly limited, examples of the betaine-type surfactant include lauryl dimethyl betaine, dimethyl stearyl betaine, dihydroxy lauryl betaine, palm oil fatty acid amidopropyl dimethyl amino acetic acid betaine, palm oil fatty acid amidopropyl betaine, lauric acid amidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryl dimethyl amino acetic acid betaine, and myristic acid amidopropyl dimethyl amino betaine.

[0059] Although not particularly limited, examples of the amino acid-type surfactant include a sodium salt of lauryl aminopropionic acid and a sodium salt of stearyl propionic acid.

[0060] In the present embodiment, from the viewpoint of more effectively exhibiting the action effect, it is also preferable to include a mixture of an alkylbenzene sulfonate, a nonionic surfactant having an aryl ether, and a polyoxyethylene castor oil ether.

[0061] Examples of the solvents and oils include solvents and oils other than the aprotic polar solvents. Although not particularly limited, examples thereof include ethanol, isopropanol, 1-butanol, polyethylene glycol, polypropylene glycol, acetic acid, acetic anhydride, acetophenone, methyl oleate, palm oil, rapeseed oil, soybean oil, castor oil, linseed oil, paraffin oil, kerosene, cyclohexanol, γ-butyrolactone, a fatty acid methyl ester, dimethyl sulfoxide, chlorobenzene, chlorotoluene, dichloroaniline, toluene, xylene, an alkyl benzene, normal paraffin, dimethyl phthalate, diethyl phthalate, dibutyl phthalate, cyclohexanone, acetonitrile, lamp oil, machine oil, and an aromatic solvent.

[0062] The solvent content in the composition of surfactant other than the above-described aprotic polar solvents is not particularly limited; however, it is preferably 20% by mass or less and more preferably 10% by mass or less with respect to 100% by mass of the composition according to the present embodiment, and it may be 5% by mass or less, 4% by mass or less, 3% by mass or less, 2% by mass or less, 1% by mass or less, 0.5% by mass or less, 0.4% by mass or less, or 0.3% by mass or less. The agricultural chemical composition according to the present embodiment may not contain a surfactant other than the ether-type ionic surfactant.

[0063] Although not particularly limited, examples of the sugars include water-containing α-lactose, anhydrous α-lactose, anhydrous β-lactose, a diol compound, a glycerin and a derivative thereof, penterythritol, sorbitol, xylitol, sucrose, glucose, and fructose.

[0064] Although not particularly limited, examples of the water-soluble polymers include xanthan gum, methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, polyvinyl alcohol, starch, dextrin, and polyvinyl pyrrolidone.

[0065] Although not particularly limited, examples of the inorganic salts include calcium silicate, magnesium carbonate, calcium carbonate, sodium carbonate, sodium bicarbonate, ammonium sulfate, sodium sulfate, magnesium sulfate, diammonium hydrogen phosphate, ammonium dihydrogen phosphate, and potassium chloride. 　　　　Although not particularly limited, examples of the ultraviolet shielding agent include a salicylic acid-based ultraviolet shielding agent and a benzophenone-based ultraviolet shielding agent.

[0066] Although not particularly limited, examples of the latexes and emulsions include latexes and emulsions such as a styrene-butadiene copolymer, a styrene-acrylic copolymer, a methyl methacrylate-butadiene copolymer, an ethylene-vinyl acetate copolymer, an ethylene-acrylic copolymer, a silicone-acrylic copolymer, polyurethane, and polyurea.

[0067] Although not particularly limited, examples of the anti-foaming agent include lower alcohol-based anti-foaming agents such as methanol, ethanol, propanol, isopropanol, sec-butanol, and butanol; organic polar compound-based anti-foaming agents such as amyl alcohol, diisobutyl carbitol, tributyl phosphate, oleic acid, tall oil, metallic soap, a sorbitan lauric acid monoester, a sorbitan lauric acid triester, a polyethylene glycol fatty acid ester, a Pluronic (Poloxamer)-type nonionic surfactant, and an acetylene glycol derivative; and silicone resin-based anti-foaming agents such as a silicone resin, a surfactant blend of a silicone resin, and an inorganic powder blend of a silicone resin.

[0068] Although not particularly limited, examples of the pH adjusting agent include inorganic acids such as phosphoric acid; organic acids such as citric acid, phthalic acid, and succinic acid; organic metal salts such as sodium citrate and potassium hydrogen phthalate; inorganic metal salts such as disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, and sodium borate; hydroxides such as sodium hydroxide and potassium hydroxide; and organic amines such as triethanolamine.

[0069] Although not particularly limited, examples of the flavoring agents include lavender oil, jasmine oil, rose oil, lemon oil, orange oil, peppermint oil, thyme oil, calamus oil, fennel oil, cedar oil, Thujopsis dolabrata oil, Japanese cypress oil, eucalyptus oil, camphor, peppermint oil, spearmint oil, geraniol, citronellal, eugenol, limonene, citrus oil, Japanese spruce oil, and citronellol.

[0070] Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples, and Test Examples; however, the present invention is not intended to be limited thereto in any way.Test 1 (Composition stability test)

[0071] A 50 mL glass bottle with a lid was filled with 30 g of a composition obtained from each of Example 1 to Example 16 and Comparative Example 1 to Comparative Example 26, and then, sealed and allowed to stand for 30 days in environments of 20°C to 25°C, -5°C, and -15°C. Then, the appearance of the compositions was visually observed and evaluated based on the following criteria. It is noted that in a case where residues were observed after filtration through a 75 μm filter, it was determined that crystal precipitation occurred. The results are shown in Table 1. 　　　　(Criteria) 　　　　A: No crystal precipitation is observed under any temperature conditions. 　　　　B: Although crystal precipitation is observed in a case of storage at -5°C and -15°C, the crystals dissolve within a few hours in a case of being allowed to stand at room temperature, thereby returning to the original formulation stock solution which is uniform. 　　　　C: Crystal precipitation is observed under any temperature conditions, and the crystals do not dissolve even after being allowed to stand for a long period at room temperature.Test 2 (Emulsification stability test)

[0072] About 99.95 mL of a standard hard water at 20°C was put into a 250 mL stoppered graduated cylinder, 50 μL of the composition obtained from each of Example 1 to Example 16 and Comparative Example 1 to Comparative Example 26 was collected with a micropipette, poured gently onto the water surface, capped with a lid, and subjected to mixing by 30 times of vigorous inversion in one minute, and after being allowed to stand for 2 hours or after being allowed to stand for 5 hours in a 20°C incubator, the state of the diluted solution was visually observed, and the emulsification stability was evaluated based on the following criteria. 　　　　(Standard hard water) 　　　　The standard hard water used is a 19-degree hard water, and standard water D (MT18.1.4 WHO standard hard water), which is a CIPAC standard water (MT18.1), can be substituted. Standard water D has, hardness at 342 ppm: pH 6.0 to 7.0, and Ca:Mg = 80:20. The 19-degree hard water is a hard water that may be classified as soft water under certain classifications. 　　　　(Criteria) 　　　　A: A uniform emulsion (diluted solution) is maintained. 　　　　A to B: In a case where the cylinder is slowly tilted, a creamy sediment accumulates at the bottom part. This sediment disappears after several times of shaking, and then a uniform emulsion is maintained. 　　　　B: In a case where the cylinder is slowly tilted, a creamy sediment accumulates at the bottom part. This sediment can be re-dispersed with several times of shaking. 　　　　C: Crystal precipitation is observed.

[0073] (Production method for noxious organism control composition) 　　　　A production method for a noxious organism control composition is not particularly limited as long as it is a method that makes it possible to obtain a noxious organism control composition containing the above-described components. The noxious organism control composition of the present embodiment can be obtained by dissolving and mixing the components (1) to (4) and optionally the other components described above, by a publicly known method. 　　　　It is noted that the blending ratios between the respective components shown in the following examples and comparative examples are indicated in terms of % by mass in a case where the noxious organism control composition to be obtained is set to 100% by mass. In the following examples and comparative examples, the composition was produced, where the blending ratio between the respective components was the ratio described in the table below.

[0074] 5% by mass of broflanilide (manufactured by Mitsui Chemicals Crop & Life Solutions, Inc., the same shall apply hereinafter), 12% by weight of dinotefuran (manufactured by Mitsui Chemicals Crop & Life Solutions Inc., the same shall apply hereinafter), 80.5% by mass of N-butyl-2-pyrrolidone (Genagen NBP, manufactured by Clariant, the same shall apply hereinafter), and 2.5% by mass of a polyoxyethylene (9) tristyryl phenyl ether ammonium sulfate salt (Solpol (registered trademark) T-10SPG, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Example 1.

[0075] Hereinafter, polyoxyethylene will be denoted as POE. The numerical value in parentheses, which is described after polyoxyethylene or POE indicates the number of repetitions of polyoxyethylene.

[0076] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of 1,3-dimethyl-2-imidazolidinone (DMI, manufactured by Mitsui Chemicals, Inc., the same shall apply hereinafter), and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 2.

[0077] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of 3-methyl-2-oxazolidinone (Texnol (registered trademark) manufactured by MOZ Nippon Nyukazai Co., Ltd., the same applies hereinafter), and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 3.

[0078] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (14) tristyryl phenyl ether ammonium sulfate salt (Solpol (registered trademark) T-15SPG, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Example 4.

[0079] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (19) tristyryl phenyl ether ammonium sulfate salt (Solpol (registered trademark) T-20SPG, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Example 5.

[0080] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE distyryl phenyl ether sodium sulfate salt (Solpol (registered trademark) 7556, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Example 6.

[0081] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, and 10% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 7.

[0082] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, and 10% by mass of a POE (14) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 8.

[0083] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, and 10% by mass of a POE (19) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 9.

[0084] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, and 10% by mass of POE distyryl phenyl ether sodium sulfate salt were added and mixed until being uniform to obtain a composition of Example 10.

[0085] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, 6% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt, and 4% by mass of POE distyryl phenyl ether sodium sulfate salt were added and mixed until being uniform to obtain a composition of Example 11.

[0086] 5% by mass of broflanilide, 20% by weight of dinotefuran, 60% by mass of N-butyl-2-pyrrolidone, 5% by mass of 3-methyl-2-oxazolidinone, 5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt, and 5% by mass of a POE distyryl phenyl ether sodium sulfate salt were added and mixed until being uniform to obtain a composition of Example 12.Comparative Example 1

[0087] 5% by mass of broflanilide, 92.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Comparative Example 1.Comparative Example 2

[0088] 5% by mass of broflanilide, 92.5% by mass of 1,3-dimethyl-2-imidazolidinone (DMI(registered trademark), manufactured by Mitsui Chemicals, Inc., the same shall apply hereinafter), and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Comparative Example 2.Comparative Example 3

[0089] 5% by mass of broflanilide, 92.5% by mass of 3-methyl-2-oxazolidinone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Comparative Example 3.Comparative Example 4

[0090] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of N-butyl-2-pyrrolidone were added, and 2.5% by mass of calcium dodecylbenzenesulfonate (RHODACAL 60 / BE, manufactured by Solvay Nikka Co., Ltd.) was added and mixed until being uniform to obtain a composition of Comparative Example 4.Comparative Example 5

[0091] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of N-butyl-2-pyrrolidone were added, and 2.5% by mass of a POA allyl phenyl ether (Newcalgen CP-120, manufactured by TAKEMOTO OIL & FAT Co., Ltd.) was added and mixed until being uniform to obtain a composition of Comparative Example 5.Comparative Example 6

[0092] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of N-butyl-2-pyrrolidone were added, and 2.5% by mass of POE allyl phenyl ether (Newcalgen C-173, manufactured by TAKEMOTO OIL & FAT Co., Ltd.) was added and mixed until being uniform to obtain a composition of Comparative Example 6.Comparative Example 7

[0093] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of N-butyl-2-pyrrolidone were added, and 2.5% by mass of POE allyl phenyl ether (Newcalgen C-150, manufactured by TAKEMOTO OIL & FAT Co., Ltd.) was added and mixed until being uniform to obtain a composition of Comparative Example 7.Comparative Example 8

[0094] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether (Solpol (registered trademark) T-10, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 8.Comparative Example 9

[0095] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (14) tristyryl phenyl ether (Solpol (registered trademark) T-15, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 9.Comparative Example 10

[0096] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (19) tristyryl phenyl ether (Solpol (registered trademark) T-20, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 10.Comparative Example 11

[0097] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (21) distyryl phenyl ether formaldehyde condensate (Solpol (registered trademark) F-15, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 11.Comparative Example 12

[0098] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (26) distyryl phenyl ether formaldehyde condensate (Solpol (registered trademark) F-19, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 12.Comparative Example 13

[0099] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (34) distyryl phenyl ether formaldehyde condensate (Solpol (registered trademark) F-24, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 13.Comparative Example 14

[0100] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (38) distyryl phenyl ether formaldehyde condensate (Solpol (registered trademark) F-27, manufactured by Toho Chemical Industry Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 14.Comparative Example 15

[0101] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of an ethoxylated propoxylated polyarylphenol (Soprophor (registered trademark) 796P, manufactured by Solvay Nikka Co., Ltd., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 15.Comparative Example 16

[0102] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE castor oil ether (TERGITOL (registered trademark) ECO-36, manufactured by Dow Inc., the same shall apply hereinafter) were added and mixed until being uniform to obtain a composition of Comparative Example 16.Comparative Example 17

[0103] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of 1,3-dimethyl-2-imidazolidinone were added, and 2.5% by mass of calcium dodecylbenzenesulfonate was added and mixed until being uniform to obtain a composition of Comparative Example 17.Comparative Example 18

[0104] 5% by mass of broflanilide, 12% by weight of dinotefuran, and 80.5% by mass of 3-methyl-2-oxazolidinone were added, and 2.5% by mass of calcium dodecylbenzenesulfonate was added and mixed until being uniform to obtain a composition of Comparative Example 18.Comparative Example 19

[0105] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of 1,3-dimethyl-2-imidazolidinone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 19.Comparative Example 20

[0106] 5% by mass of broflanilide, 12% by weight of dinotefuran, 80.5% by mass of 3-methyl-2-oxazolidinone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 20.

[0107] Examples 1 to 12 and Comparative Examples 1 to 20 were subjected to a test 1 and a test 2. The results are shown in Table 1 to Table 5.

[0108] (Table 1)

[0109] (Table 2)

[0110] (Table 3)

[0111] (Table 4)

[0112] (Table 5)

[0113] In Tables 1 to 5, I1 is broflanilide, I2 is dinotefuran, I3 is N-butyl-2-pyrrolidone, I4 is 1,3-dimethyl-2-imidazolidinone, and I5 is 3-methyl-2-oxazolidinone. 　　　　In addition, S1 is a POE (9) tristyryl phenyl ether ammonium sulfate salt, S2 is a POE (14) tristyryl phenyl ether ammonium sulfate salt, S3 is a POE (19) tristyryl phenyl ether ammonium sulfate salt, S4 is a POE distyryl phenyl ether sodium sulfate salt, S5 is calcium dodecylbenzenesulfonate, S6 is a POA allyl phenyl ether, S7 is a POE allyl phenyl ether, S9 is a POE (9) tristyryl phenyl ether, S10 is a POE (14) tristyryl phenyl ether, S11 is a POE (19) tristyryl phenyl ether, S12 is a POE (21) distyryl phenyl ether formaldehyde condensate, S13 is a POE (26) distyryl phenyl ether formaldehyde condensate, S14 is a POE (34) distyryl phenyl ether formaldehyde condensate, S15 is a POE (38) distyryl phenyl ether formaldehyde condensate, S16 is an ethoxylated propoxylated polyarylphenol, and S17 is a POE castor oil ether.

[0114] I1 corresponds to the compound described in (1) in the present invention. I2 corresponds to the compound described in (2) in the present invention. I3 to I5 correspond to the compound described in (3) in the present invention. S1 to S17 correspond to the compound described in (4) in the present invention.

[0115] In Tables 1 to 5, P1 is Genagen NBP, P2 is DMI, P3 is Texnol MOZ, P4 is Solpol T-10SPG, P5 is Solpol T-15SPG, P6 is Solpol T-20SPG, P7 is Solpol 7556, P8 is RHODACAL 60 / BE, P9 is Newcalgen CP-120, P10 is Newcalgen C-173, P11 is Newcalgen C-150, P12 is Solpol T-10, P13 is Solpol T-15, P14 is Solpol T-20, P15 is Solpol F-15, P16 is Solpol F-19, P17 is Solpol F-24, P18 is Solpol F-27, P19 is Soprophor 796P, and P20 is TERGITOL ECO-36. In addition, ST1 is an ether-type ionic surfactant, ST2 is an alkyl-type ionic surfactant, and ST3 is an ether-type nonionic surfactant.

[0116] As shown in Table 3, in the compositions of Comparative Examples 1 to 3, which contain the poorly water-soluble noxious organism control component (1) which does not include the easily water-soluble noxious organism control component (2), and contains an ether-type ionic surfactant, crystal precipitation was observed under any temperature conditions in a case of being allowed to stand within 30 days. On the other hand, in the compositions stored at -5°C and -15°C, the precipitated crystals did not dissolve even after being allowed to stand at room temperature, and the compositions have low stability at or below ordinary temperature. In addition, as shown in Tables 3 to 5, in any of the compositions of Comparative Examples 5 to 16 and Comparative Examples 19 and 20, which contain an ether-type nonionic surfactant that does not include the ether-type ionic surfactant, a uniform emulsion could not be maintained, and the emulsification stability was low in the test 2. Further, as shown in Tables 3 and 5, emulsification stability was low even in the compositions of Comparative examples 4, 17, and 18, which contain a surfactant that is not the ether-type surfactant but is the ionic surfactant.

[0117] On the other hand, as shown in Tables 1 and 2, crystal precipitation was not observed in the compositions of Examples after long-term storage at or below ordinary temperature, and the composition stability was excellent. Further, in the compositions of Examples, it was found that the diluted solution maintains a uniform emulsion and has excellent emulsification stability even after being allowed to stand for 2 hours or more in the test 2.

[0118] 5% by mass of cyproflanilide, 12% by mass of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 13.

[0119] 5% by mass of fluxametamide (analytical standard product, manufactured by FUJIFILM Wako Pure Chemical Corporation, the same shall apply hereinafter), 12% by mass of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 14.Comparative Example 21

[0120] 5% by mass of cyproflanilide, 12% by mass of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 21.Comparative Example 22

[0121] 5% by mass of fluxametamide, 12% by mass of dinotefuran, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 22.Comparative Example 23

[0122] 5% by mass of cyproflanilide, 92.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Comparative Example 23.Comparative Example 24

[0123] 5% by mass of fluxametamide, 92.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Comparative Example 24.

[0124] Examples 13 and 14, and Comparative Examples 21 to 24 were subjected to the test 1 and the test 2. The results are shown in Table 6.

[0125] (Table 6)

[0126] In Table 6, I6 is cyproflanilide , and I7 is fluxametamide. The compounds I6 and I7 correspond to the compound described in (1) in the present invention. As shown in Table 6, in the compositions of Comparative Examples 1, 23, and 24, which contain the poorly water-soluble noxious organism control component (1) which does not include the easily water-soluble noxious organism control component (2), and contains an ether-type ionic surfactant, crystal precipitation was observed under any temperature conditions in a case of being allowed to stand within 30 days. In a case of being stored at -5°C and -15°C, the precipitated crystals did not dissolve even after being allowed to stand at room temperature. As described above, in Comparative Examples 1, 23, and 24, the compositions have low stability at or below ordinary temperature. In the compositions of Comparative Examples 8, 21, and 22, which contain (1) a poorly water-soluble noxious organism control component in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less, (2) an easily water-soluble noxious organism control component in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less, and an ether-type nonionic surfactant, the diluted solution did not maintain a uniform emulsion and had low emulsification stability even after being allowed to stand for 2 hours or more in the test 2.

[0127] On the other hand, crystal precipitation was not observed in the compositions of Examples 1, 13, and 14 after long-term storage at or below ordinary temperature, and the composition stability was excellent. Further, in the compositions of Examples 1, 13, and 14, it was found that the diluted solution maintains a uniform emulsion and has excellent emulsification stability even after being allowed to stand for 2 hours or more in the test 2.

[0128] 5% by mass of broflanilide, 12% by mass of flonicamid, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 15.

[0129] 5% by mass of broflanilide, 12% by mass of hymexazol, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether ammonium sulfate salt were added and mixed until being uniform to obtain a composition of Example 16.Comparative Example 25

[0130] 5% by mass of broflanilide, 12% by mass of flonicamid, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 25.Comparative Example 26

[0131] 5% by mass of broflanilide, 12% by mass of hymexazol, 80.5% by mass of N-butyl-2-pyrrolidone, and 2.5% by mass of a POE (9) tristyryl phenyl ether were added and mixed until being uniform to obtain a composition of Comparative Example 26.

[0132] Examples 15 and 16, and Comparative Examples 25 and 26 were subjected to the test 1 and the test 2. The results are shown in Table 7. In addition, the results of the test 1 and the test 2 for Example 1 and Comparative Example 8 are also shown for comparison.

[0133] (Table 7)

[0134] In Table 7, I8 is flonicamid, and I9 is hymexazol. The compounds I8 and I9 correspond to the compound described in (2) in the present invention. As shown in Table 7, all the compositions of Comparative Examples 8, 25, and 26, which contain (1) a poorly water-soluble noxious organism control component in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less, (2) an easily water-soluble noxious organism control component in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less, and an ether-type nonionic surfactant, were poured gently onto the water surface, capped with a lid, and subjected to mixing by 30 times of vigorous inversion in one minute. As a result, the diluted solution did not maintain a uniform emulsion and had low emulsification stability even after being allowed to stand for 5 hours or more in a 20°C incubator.

[0135] On the other hand, the compositions of Examples 1, 15, and 16 which contain an ether-type ionic surfactant were poured gently onto the water surface, capped with a lid, and subjected to mixing by 30 times of vigorous inversion in one minute. As a result, it was found that the diluted solution maintains a uniform emulsion and has excellent emulsification stability even after being allowed to stand for 2 hours or more in a 20°C incubator.

[0136] Through the tests on examples and comparative examples described above, it has been experimentally confirmed that the effect of the present invention is established in a case of combining (1), (2), (3), and (4), which are described above, and cannot be established in a case of lacking any one of these components.

Claims

1. A noxious organism control composition, comprising: 　　　　(1) at least one kind of compound selected from the group consisting of poorly water-soluble noxious organism control components in which a solubility in water at 20°C is 0.00002 g / L or more and 0.200 g / L or less; 　　　　(2) at least one kind of compound selected from the group consisting of easily water-soluble noxious organism control components in which a solubility in water at 20°C is 3.8 g / L or more and 500 g / L or less; 　　　　(3) an aprotic polar solvent; and 　　　　(4) an ether-type ionic surfactant.

2. The noxious organism control composition according to Claim 1, 　　　　wherein the compound described in (1) is at least one selected from the group consisting of a meta-diamide-based insecticide, an isoxazoline-based insecticide, a diamide-based insecticide, a phenylpyrazole-based insecticide, a neonicotinoid-based insecticide, and a pyrethroid-based insecticide, and 　　　　the compound described in (2) is at least one selected from the group consisting of a neonicotinoid-based insecticide, a pyridine-based insecticide, and an isoxazole-based insecticide.

3. The noxious organism control composition according to Claim 1 or 2, 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, piperflanilide, fluxametamide, isocycloseram, isoflualanam, chlorantraniliprole, cyantraniliprole, cyclaniliprole, tetratraniliprole, flubendiamide, nicofluprole, flupyrimin, and etofenprox.

4. The noxious organism control composition according to Claim 1 or 2, 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, nicofluprole, fluxametamide, and isocycloseram.

5. The noxious organism control composition according to Claim 1 or 2, 　　　　wherein the compound described in (1) is at least one selected from the group consisting of broflanilide, cyproflanilide, and fluxametamide.

6. The noxious organism control composition according to Claim 1 or 2, 　　　　wherein the compound described in (1) is broflanilide.

7. The noxious organism control composition according to any one of Claims 1 to 6, 　　　　wherein the compound described in (2) is at least one selected from the group consisting of dinotefuran, flonicamid, and hydroxyisoxazole.

8. The noxious organism control composition according to any one of Claims 1 to 6, 　　　　wherein the compound described in (2) is at least one selected from the group consisting of dinotefuran and flonicamid.

9. The noxious organism control composition according to any one of Claims 1 to 6, 　　　　wherein the compound described in (2) is dinotefuran.

10. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of amides, ureas, and carbamates.

11. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of cyclic amides, cyclic ureas, and cyclic carbamates.

12. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of an N-alkyl pyrrolidone, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone (provided that an N-alkyl group has 1 to 8 carbon atoms).

13. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, and 3-methyl-2-oxazolidinone.

14. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone or N-methyl-2-pyrrolidone.

15. The noxious organism control composition according to any one of Claims 1 to 9, 　　　　wherein the aprotic polar solvent is N-butyl-2-pyrrolidone.

16. The noxious organism control composition according to any one of Claims 1 to 15, 　　　　wherein the ether-type ionic surfactant is an ether-type anionic surfactant.

17. The noxious organism control composition according to Claim 16, 　　　　wherein the ether-type anionic surfactant includes at least one selected from salts having a polyoxyalkylene aryl ether.

18. The noxious organism control composition according to Claim 16, 　　　　wherein the ether-type anionic surfactant includes at least one selected from a polyoxyethylene distearyl phenyl ether sulfate and a polyoxyethylene tristearyl phenyl ether sulfate.

19. The noxious organism control composition according to any one of Claims 1 to 6, 　　　　wherein the compound described in (1) is broflanilide, 　　　　and the compound described in (2) is dinotefuran.

20. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of amides, ureas, and carbamates.

21. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of cyclic amides, cyclic ureas, and cyclic carbamates.

22. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of an N-alkyl pyrrolidone, an N-alkyl imidazolidinone, and an N-alkyl oxazolidinone (provided that an N-alkyl group has 1 to 8 carbon atoms).

23. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, and 3-methyl-2-oxazolidinone.

24. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent includes at least one selected from the group consisting of N-butyl-2-pyrrolidone or N-methyl-2-pyrrolidone.

25. The noxious organism control composition according to Claim 19, 　　　　wherein the aprotic polar solvent is N-butyl-2-pyrrolidone.

Images